Analysts' Actions: ABT AMZN CROX DF TRIP


American Assets Trust ( AAT) was upgraded to hold at TheStreet Ratings.

Abbott (ABT) price target cut was at Jefferies. The 12-month price target is now $46. Pricing pressure in EPS and FX exposure, Jefferies said. Buy rating.

(AMZN) was downgraded at UBS to neutral from buy. Driven by surprise deceleration in revenue and paid unit growth trends, UBS said. Also, proprietary survey indicated that raising Amazon Prime price would result in drop of renewals, UBS said. Twelve-month price target is $375.

Crox (CROX) was upgraded at Piper Jaffray to overweight from neutral. Twelve-month price target is $20. Demand appears to be improving in Asia, which drives a large amount of sales, Piper Jaffray said.

Dean Foods (DF) was downgraded at Stifel Nicolaus to hold from buy. Company lacks near-term visibility, Stifel Nicolaus said.

Ecopetrol (EC) was downgraded to hold at TheStreet Ratings.
(HUN) was downgraded at Citigroup to neutral from buy. Twelve-month price target is $27. Company lacks near-term catalysts, Citigroup said.

Itron (ITRI) was upgraded at Needham to buy from hold. Twelve-month price target is $45. Business appears poised to turn around in 2014, Needham said.

RBC Bearings (ROLL) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $75. Aerospace and defense demand remains strong, and the worst of the industrial business is likely already behind the company, BofA/Merrill said.

Senior Housing Properties Trust (SNH) was downgraded at UBS to sell from neutral. Minimal accretion for large acquisition and unjustified 24% G&A increase, UBS said. Twelve-month price target is $19.

If you liked this article you might like

The Best Companies for Women

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Alibaba, Qorvo, Abbott Laboratories, Square: 'Mad Money' Lightning Round

Walmart Is One of 63 Companies Contributing Massively to Aid Harvey Relief